Abstract
A locus on chromosome 9q22 harbors a SNP (rs965513) firmly associated with risk of papillary thyroid carcinoma (PTC). The locus also comprises the forkhead box E1 (FOXE1) gene, which is implicated in thyroid development, and a long noncoding RNA (lncRNA) gene, papillary thyroid cancer susceptibility candidate 2 (PTCSC2). How these might interact is not known. Here we report that PTCSC2 binds myosin-9 (MYH9). In a bidirectional promoter shared by FOXE1 and PTCSC2, MYH9 inhibits the promoter activity in both directions. This inhibition can be reversed by PTCSC2, which acts as a suppressor. RNA knockdown of FOXE1 in primary thyroid cells profoundly interferes with the p53 pathway. We propose that the interaction between the lncRNA, its binding protein MYH9, and the coding gene FOXE1 underlies the predisposition to PTC triggered by rs965513.
Author supplied keywords
Cite
CITATION STYLE
Wang, Y., He, H., Li, W., Phay, J., Shen, R., Yu, L., … De La Chapelle, A. (2017). MYH9 binds to lncRNA gene PTCSC2 and regulates FOXE 1 in the 9q22 thyroid cancer risk locus. Proceedings of the National Academy of Sciences of the United States of America, 114(3), 474–479. https://doi.org/10.1073/pnas.1619917114
Register to see more suggestions
Mendeley helps you to discover research relevant for your work.